Evidence map›Paper›PMID 27426098›Full record

ArticleThe Journal of physiology2016

Exogenous and endogenous angiotensin-II decrease renal cortical oxygen tension in conscious rats by limiting renal blood flow.

Tonja W Emans, Ben J Janssen, Maximilian I Pinkham, Connie P C Ow, Roger G Evans, Jaap A Joles, Simon C Malpas, C T Paul Krediet, Maarten P Koeners

Open access · hybridAbstract read
In one paragraph

Article in The Journal of physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Hypoxia-Inducible Factors and Diabetic Kidney Disease-How Deep Can We Go?International journal of molecular sciences · 2022
    Review
  3. Renal blood flow and oxygenation.Pflugers Archiv : European journal of physiology · 2022
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Protective potential of curcumin in L-NAME-induced hypertensive rat model: AT1R, mitochondrial DNA synergy.International journal of physiology, pathophysiology and pharmacology · 2020
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 5 countries.

Tonja W EmansNephrology and Hypertension, University Medical Centre Utrecht, Utrecht, The Netherlands.
Ben J JanssenDepartment of Pharmacology and Toxicology, Maastricht University, Maastricht, The Netherlands.
Maximilian I PinkhamDepartment of Physiology, University of Auckland, Auckland, New Zealand.
Connie P C OwCardiovascular Disease Program, Biosciences Discovery Institute and Department of Physiology, Monash University, Melbourne, Australia.
Roger G EvansCardiovascular Disease Program, Biosciences Discovery Institute and Department of Physiology, Monash University, Melbourne, Australia.
Jaap A JolesNephrology and Hypertension, University Medical Centre Utrecht, Utrecht, The Netherlands.
Simon C MalpasDepartment of Physiology, University of Auckland, Auckland, New Zealand.
C T Paul KredietInternal Medicine-Nephrology, Academic Medical Centre at the University of Amsterdam, The Netherlands.
Maarten P KoenersSchool of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK. m.koeners@bristol.ac.uk.
Academic Medical Center · NLUniversity of Auckland · NZDiscovery Institute · USMaastricht University · NLMonash University · AUUniversity Medical Center Utrecht · NLUniversity of Bristol · GB

Funding

British Heart Foundation FS/14/2/30630
6 · The paper itself

Abstract

key pointsOur understanding of the mechanisms underlying the role of hypoxia in the initiation and progression of renal disease remains rudimentary. We have developed a method that allows wireless measurement of renal tissue oxygen tension in unrestrained rats. This method provides stable and continuous measurements of cortical tissue oxygen tension (PO2) for more than 2 weeks and can reproducibly detect acute changes in cortical oxygenation. Exogenous angiotensin-II reduced renal cortical tissue PO2 more than equi-pressor doses of phenylephrine, probably because it reduced renal oxygen delivery more than did phenylephrine. Activation of the endogenous renin-angiotensin system in transgenic Cyp1a1Ren2 rats reduced cortical tissue PO2; in this model renal hypoxia precedes the development of structural pathology and can be reversed acutely by an angiotensin-II receptor type 1 antagonist. Angiotensin-II promotes renal hypoxia, which may in turn contribute to its pathological effects during development of chronic kidney disease. ABSTRACT: We hypothesised that both exogenous and endogenous angiotensin-II (AngII) can decrease the partial pressure of oxygen (PO2) in the renal cortex of unrestrained rats, which might in turn contribute to the progression of chronic kidney disease. Rats were instrumented with telemeters equipped with a carbon paste electrode for continuous measurement of renal cortical tissue PO2. The method reproducibly detected acute changes in cortical oxygenation induced by systemic hyperoxia and hypoxia. In conscious rats, renal cortical PO2 was dose-dependently reduced by intravenous AngII. Reductions in PO2 were significantly greater than those induced by equi-pressor doses of phenylephrine. In anaesthetised rats, renal oxygen consumption was not affected, and filtration fraction was increased only in the AngII infused animals. Oxygen delivery decreased by 50% after infusion of AngII and renal blood flow (RBF) fell by 3.3 ml min

Indexed as

Oxygen ConsumptionRenal CirculationAngiotensin IIAngiotensin Receptor AntagonistsAnimalsConsciousnessCytochrome P-450 CYP1A1KidneyMalePhenylephrineRatsRats, WistarReninRenin-Angiotensin SystemVasoconstrictor AgentsAngiotensin IIAngiotensin Receptor AntagonistsCytochrome P-450 CYP1A1PhenylephrineRen2 protein, ratReninVasoconstrictor Agentsangiotensin-IIcortexCyp1a1Ren2 transgenic rathypoxiakidneyoxygenationphenylephrinetelemetry

Identifiers

PMID27426098
PMCPMC5088249
OpenAlexW2500395645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.